Ustekinumab dose escalation improves clinical responses in refractory Crohn's disease.
Haider SA, Yadav A, Perry C, Su L, Akanbi O, Kudaravalli P, Tripathi N, Hashim MA, Abdelsalam M, Hussein M, Elkheshen A, Patel V, Ali SE, Lamb L, Ingram K, Mayne C, Stuffelbeam AB, Flomenhoft D, Stromberg A, Barrett TA.
Haider SA, et al. Among authors: su l.
Therap Adv Gastroenterol. 2020 Oct 13;13:1756284820959245. doi: 10.1177/1756284820959245. eCollection 2020.
Therap Adv Gastroenterol. 2020.
PMID: 33133239
Free PMC article.